Synthon welcomes Anish Mehta to its Board of Directors as CEO

– NETHERLANDS, Nijmegen –  Synthon BV, an international, science-centered pharmaceutical company specialized in developing and manufacturing high-quality generic and hybrid medicines for patients around the world, today announced the appointment of Anish Mehta as CEO and member of the Board of Directors, effective immediately.…

Biomarck Pharmaceuticals welcomes Dr. Graham Lumsden as CEO

– USA, NC –  Biomarck Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company developing anti-inflammatory and oncological therapies that target the MARCKS protein, today announced the appointment of Dr.

Terns Pharmaceuticals strengthens its Board with new Independent Directors

– USA, CA –  Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases, today announced the additions of industry leaders David Fellows, Jeff Kindler, and Jill Quigley to its Board as Independent Directors.…